Aprea Therapeutics, Inc. (APRE)
Operating Cash Flow (Statement)
-$12.17M
TTM · Period ending: · USD
APRE Operating Cash Flow (Statement)
Latest reported-$12.17Mperiod ending
Latest reported-$12.17Mperiod ending
APRE Cash from Operations (-$14.00M → -$12.17M)
Annual operating cash flow (statement)
High-resolution chart · PNG
APRE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -12,894,439 | |
| -13,556,718 | |
| -12,177,608 | |
| -25,011,136 | |
| -37,686,179 | |
| -41,802,672 | |
| -26,708,707 | |
| -15,250,234 | |
| -14,002,118 |